Virta Health
Nutrition-first virtual metabolic care company focused on weight loss, type 2 diabetes reversal/remission, and reducing dependence on costly medications. Virta's model differs from most companies in this directory in a specific way: it leads with a nutrition-based intervention (typically very-low-carbohydrate) and positions GLP-1 medications as a complement or off-ramp rather than the primary treatment. Patients who want or need GLP-1s can access them, but the clinical philosophy centers on reducing medication dependence over time. Offers care teams, app, and structured nutritional therapy.
Access model
Primarily employers and health plans; some individual access pathways
Editorial note
More differentiated on metabolic-disease reversal and nutrition-first care than on maximizing GLP-1 prescribing.
Coverage and cost
Often covered through employer/health-plan benefits; individual availability varies
Not publicly disclosed
No public emphasis; model often aims to reduce or avoid GLP-1 utilization over time
Market signals
Evidence and positioning
One of the strongest evidence bases in the set. Virta research says patients sustained 12% body-weight loss over a year; 2025 annual report highlights 13% sustained weight loss and 60% T2D reversal, with multiple peer-reviewed metabolic studies.
This is the lower dB's current read on Virta Health's pricing posture, insurance story, medication posture, and evidence signaling.
Source References
5 public references used in this profile. Links open in a new tab for quick verification.
Pricing, insurance coverage, medication availability, and eligibility can change quickly. Verify current details directly with the provider before starting or switching care.